14.35
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.94
Aprire:
$13.95
Volume 24 ore:
173.41K
Relative Volume:
0.63
Capitalizzazione di mercato:
$265.40M
Reddito:
$62.81M
Utile/perdita netta:
$-13.75M
Rapporto P/E:
-17.94
EPS:
-0.8
Flusso di cassa netto:
$153.00K
1 W Prestazione:
+10.64%
1M Prestazione:
+8.71%
6M Prestazione:
+164.27%
1 anno Prestazione:
+34.11%
Optimizerx Corp Stock (OPRX) Company Profile
Nome
Optimizerx Corp
Settore
Industria
Telefono
248-651-6558
Indirizzo
260 CHARLES STREET, WALTHAM, MI
Confronta OPRX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
OPRX
Optimizerx Corp
|
14.35 | 257.82M | 62.81M | -13.75M | 153.00K | -0.80 |
![]()
VEEV
Veeva Systems Inc
|
290.41 | 47.59B | 2.86B | 780.66M | 1.20B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
64.49 | 10.97B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
60.77 | 11.37B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
96.04 | 8.16B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
35.83 | 6.40B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-01-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
2024-12-20 | Iniziato | Stephens | Equal-Weight |
2024-07-25 | Ripresa | B. Riley Securities | Buy |
2024-04-04 | Iniziato | JMP Securities | Mkt Outperform |
2024-01-03 | Iniziato | Barclays | Equal Weight |
2023-02-02 | Ripresa | B. Riley Securities | Buy |
2022-11-01 | Iniziato | Stifel | Buy |
2022-07-15 | Iniziato | SVB Leerink | Outperform |
2021-10-18 | Ripresa | B. Riley Securities | Buy |
2021-04-13 | Iniziato | RBC Capital Mkts | Outperform |
2019-01-03 | Iniziato | William Blair | Outperform |
Mostra tutto
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx Corp. (NASDAQ:OPRX) Shares Sold by Royce & Associates LP - MarketBeat
How many analysts rate OptimizeRx Corporation as a “Buy”Phenomenal capital gains - jammulinksnews.com
Should I hold or sell OptimizeRx Corporation stock in 2025High-octane investment opportunities await - jammulinksnews.com
Is OptimizeRx Corporation stock overvalued or undervaluedInvest smarter with expert stock recommendations - jammulinksnews.com
What catalysts could drive OptimizeRx Corporation stock higher in 2025Discover high-growth stocks for your portfolio - jammulinksnews.com
OptimizeRx Corporation Earnings Report Breakdown: What Investors Should KnowFree Premium Stock Market Reports - Newser
Is OptimizeRx Corporation Stock a Good Fit for Conservative InvestorsFast Gains With Reduced Risk - Newser
OptimizeRx Corp. (NASDAQ:OPRX) Receives $10.81 Average Price Target from Brokerages - MarketBeat
OPRX Delivers Solid Q1 Earnings: But Can It Sustain the Momentum? - The Globe and Mail
Optimizerx 15min Chart Sees KDJ Golden Cross, Bullish Marubozu Signal. - AInvest
Analysts Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $10.81 - Defense World
What analysts say about OptimizeRx Corporation stockExplosive market performance - PrintWeekIndia
Is OptimizeRx Corporation a good long term investmentFree Capital Allocation Plans - jammulinksnews.com
How OptimizeRx Corporation stock performs during market volatilityStrong Buy Recommendations - Newser
Best Growth Stocks to Buy for July 22nd - TradingView
OptimizeRx Corporation Stock Analysis and ForecastFree High-Return Strategy Alerts - jammulinksnews.com
What makes OptimizeRx Corporation stock price move sharplyProven High Yield Signals - Newser
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha
Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - The Globe and Mail
OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - The Globe and Mail
OptimizeRx Corp. to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative
Capstone Lands Major Clean Energy Win: 90% Government-Funded Microturbine Project Shows Long-Term Success - Stock Titan
OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com
Why OptimizeRx Corporation stock attracts strong analyst attentionFree Risk Assessment Services - Newser
Calamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? - sharewise.com
Best Growth Stocks To Buy For July 9th - Barchart.com
Best Growth Stocks to Buy for July 9th - The Globe and Mail
Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? - Zacks Investment Research
OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? - sharewise.com
Janney Montgomery Scott LLC Purchases 39,969 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat
OptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLC - Defense World
3,845 Shares in OptimizeRx Corp. (NASDAQ:OPRX) Bought by GAMMA Investing LLC - Defense World
Best Growth Stocks to Buy for June 25th - Yahoo Home
OptimizeRx appoints CEO Steve Silvestro to board of directors - Investing.com India
OptimizeRx appoints CEO Steve Silvestro to board of directors By Investing.com - Investing.com Nigeria
OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors - The Globe and Mail
Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire
Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance
Optimizerx Corp Azioni (OPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):